Reducing cholesterol levels and lowering the risk of liver cancer is a combined possibility with the use of Statins, a class of drugs designated to reduce cholesterol. This important class of medications has once again captured the attention of researchers, this time for its ability to potentially reduce the risks of liver cancer.
Although statins are drugs used to lower cholesterol levels and prevent other cardiovascular diseases, recent studies show statins also show great promise in preventing cancer, including liver and breast cancer.
A new research was launched involving over 30,000 people with Hepatitis B to find out more about what statins could do in protecting the body against different types of diseases. The health conditions of those who took the statins were compared with those who did not take the drug.
Hepatitis B, a condition wherein the liver is inflamed, is one of the primary causes of liver cancer. It was therefore crucial for researchers to know how statin protects and prevenst an inflamed liver from developing cancerous cells. Researchers were thrilled with findings that revealed how statin indeed reduces the risk of liver cancer. Patients who took statin proved to be less likely to have liver cancer. Further, those who took statin for a longer period showed greater resistance to liver cancer.
These findings show how statins can be strategically used in liver disease treatments. However, experts are still watching further research to learn more about any adverse effects of using the drug.
Over the years, statins have been widely prescribed to people battling high cholesterol levels. However, it is important to note that statins are also believed to have considerable but rare side effects, such as muscle damage and increased production of liver enzymes. Researchers therefore emphasize that statin, as well as other powerful drugs, should be taken with moderation and always according to a physician’s prescribed dosage. Also, patients taking statins are strongly advised to get regular liver function tests. With proper monitoring Statin’s ability to address two issues is definitely promising!
awesome blog to read…love to read it, thanks for all.http://www.maladiretasegmentada.com.br
Good job!